BioNike | Sodalis Group

Dermatological Experience and Scientific Innovation, committed to guaranteeing efficacy and high tolerability for the well-being of even the most sensitive skin.

Website Instagram TikTok

Health and Beauty

Since 1960, we have been committed to the well-being of the skin through scientific research in our laboratories and constant collaboration with dermatologists. We believe it is possible to combine high performance and high dermo-affinity for even the most sensitive skin. Therefore, we very carefully select ingredients according to their efficacy and skin tolerability profile, choosing pure and beneficial functional ingredients and totally eliminating ingredients that cause allergic reactions. For us, our dermocosmetics are works of art created with great dedication at every stage of their development. We have a vision of beauty that stems from being and not just from appearing, which is why in "bionikese" we speak of Bellessere: a beauty that stems from being and not just from appearing, that starts from feeling good in your own skin and is therefore authentic, timeless and ageless.

Beatrice Dovera

Marketing

BioNike

Our "Free From" formulation philosophy: we believe in the value of taking away to achieve more.

BioNike finds its roots in Greek etymology: Bio = life and Nike = victory meaning "Victory of Life". It therefore carries with it a very important promise, that of winning life by overcoming adversity. BioNike is the pioneering brand in Dermocosmetics for sensitive skin, the first brand to talk to dermatologists about contact allergies, especially triggered by the presence of heavy metals in formulations, and to refine a method capable of detecting even the most minute quantities of nickel. All our formulations comply with the Free From Philosophy: they are nickel tested, preservative free, fragrance free or allergen free and gluten free. Our formulation philosophy involves constant research and meticulous selection of ingredients to achieve the highest skin tolerability profile combined with the best performance profile.

BioNike for Research – Partnership with the IEO-MONZINO ETS Foundation

BioNike strengthens its commitment to support Health research and women in Science with the ‘Women in Research’ project.

We are pleased to announce the winner of the scholarship funded by BioNike as part of the IEO-MONZINO Foundation's Partners for Research program, which has been supporting clinical and experimental research at the European Institute of Oncology and the Monzino Cardiology Center for over 30 years, internationally recognized Italian centers of excellence.
Dr. Marica Rosaria Ippolito, 32, was selected as the scholarship winner for her innovative research in the field of experimental oncology.

Currently, Dr. Ippolito conducts her research at the Genome Integrity laboratory at the European Institute of Oncology (IEO), under the supervision of Professor Stefano Santaguida.
Her project focuses on studying aneuploidy in cancer, a condition characterized by an abnormal number of chromosomes, which affects over 90% of solid tumors.
The goal of her research is to understand how these chromosomal alterations impact cellular physiology and may lead to the development of new therapeutic strategies.

'Receiving a scholarship like those from the IEO-MONZINO ETS Foundation is essential for me and everyone working in the field of research,' stated Dr. Marica Rosaria Ippolito. 'Scientific research is a long and complex journey that requires time, resources, and continuous support. Every day, we face new challenges in the lab, seeking new discoveries that can make a difference in patients' lives. Without the support of scholarships, it would be difficult to fully dedicate ourselves to this mission.'

The certificate award ceremony took place on Wednesday, October 23, at the Aula Magna of the University of Milan, where Dr. Ippolito officially received the scholarship. This important recognition marks a new starting point for her research, which will progress throughout 2025.
During the year, we, together with the IEO-MONZINO ETS Foundation, will meet with the scholarship recipient to discuss and share the results and advancements achieved.
The scholarship, besides representing a crucial opportunity for Dr. Ippolito's professional growth, will play a key role in supporting the advancement of cancer research, contributing to new discoveries and improvements in treatment strategies.

By funding this scholarship as part of the IEO-MONZINO ETS Foundation’s Partners for Research program, we further strengthen our commitment to supporting scientific research and enhancing female talent.
This project is a natural extension of our mission, which combines innovation and social responsibility to protect the health and well-being of consumers.
Supporting talented researchers like Dr. Ippolito not only contributes to the development of new cancer treatments but also sends a concrete message about the importance of promoting female presence in the scientific world, offering real opportunities for the progress and excellence of Italian research.